Medibact GuidesShop at Medibact

Stacking Module

GHK-Cu Stacking Module

GHK-Cu is the component that converts the two-peptide Wolverine pairing into GLOW, and GLOW into KLOW — it is in both of the best-known pre-mixed blends. Its stacking picture carries one caveat that applies to nothing else in the repair category: the compound's strongest human evidence is for a completely different route of administration than the blends use.

GHK-Cu Guide at MedibactGHK-Cu calculatorPeptide Stacking Guide

Educational use only — not medical advice. This page summarizes information reported in published research and community practice for educational purposes. It is not medical advice and not a recommendation to use any compound. Any doses, schedules, or combinations shown are examples of what has been reported, not instructions for you. Many peptides described here are research compounds that are not FDA-approved for the uses discussed and may be investigational or restricted. Effects, risks, and legal status vary; individual needs and results vary. Consult a qualified, licensed healthcare professional before making any decision. Do not use this content to diagnose, treat, or dose yourself.

How to think about stacking GHK-Cu

  • GHK-Cu's best human evidence is topical, measured on skin-appearance endpoints. Injectable systemic use has no established human dose and a far thinner evidence base — so the strength of the cosmetic literature does not underwrite an injected blend.
  • It is a copper-delivery molecule, not just a peptide. Copper is cumulative in the body, which is why sources consistently describe conservative amounts and defined breaks rather than continuous use — a constraint the other repair compounds do not share.
  • A blue tint in any reconstituted blend containing GHK-Cu is expected and comes from the copper complex, not contamination.
  • It is dosed in milligrams, unlike BPC-157's micrograms — another scale mismatch to recompute rather than carry across.

Combinations in detail

GLOW

GHK-Cu + BPC-157 + TB-500
Why it is proposed
GHK-Cu is what defines this blend. The stated premise is that copper-driven matrix remodeling and collagen synthesis complement the repair signaling of the other two — genuinely different mechanisms rather than three versions of the same one.
What is reported in practice
Usually a pre-mixed blend vial administered as a single draw. Reported practice describes defined blocks of weeks, with the copper content the usual stated reason for taking breaks.
Cautions specific to this combination
The topical-versus-injected evidence gap is the main one. Beyond that, cumulative copper exposure is the constraint that should govern duration, and it is a property of this component specifically rather than of the blend as a whole.

KLOW

GHK-Cu + BPC-157 + TB-500 + KPV
Why it is proposed
GLOW with KPV's anti-inflammatory signaling added. GHK-Cu's role is unchanged; the addition targets the inflammatory side rather than the structural one.
What is reported in practice
The standard 80 mg four-component blend vial. GHK-Cu is often the largest single component by mass in reported splits, which is worth knowing given the copper consideration.
Cautions specific to this combination
If GHK-Cu is the largest component of an 80 mg blend, the copper exposure per draw is correspondingly higher than in a smaller GHK-Cu-only vial — and because splits are not standardised, that quantity varies by vendor.

Cosmetic copper pairing

GHK-Cu + AHK-Cu
Why it is proposed
Discussed in skin and hair contexts, where AHK-Cu is presented as a complementary copper tripeptide. This pairing sits closest to the route GHK-Cu actually has human evidence for.
What is reported in practice
Predominantly topical, as serums or creams rather than injection — which is also why AHK-Cu is deliberately excluded from the injectable reconstitution tooling on this site.
Cautions specific to this combination
Two copper-carrying compounds together compounds the cumulative-copper consideration. Topical use limits systemic exposure, which is part of why this pairing is discussed topically.

Inflammation-focused pairing

GHK-Cu + KPV
Why it is proposed
Both are studied in skin contexts from different angles — GHK-Cu for remodeling, KPV for inflammatory signaling — so the pairing is discussed where inflamed or reactive skin is the focus.
What is reported in practice
Reported both as separate compounds and as two of KLOW's four components.
Cautions specific to this combination
Evidence for the pair is absent; both individual literatures are also thin for injected systemic use specifically.

What to avoid, and why

  • Reading topical GHK-Cu evidence as support for injected use, or for an injectable blend containing it — different route, different evidence base.
  • Continuous long-run use without breaks, given cumulative copper exposure; this is the most compound-specific constraint in the repair category.
  • Stacking multiple copper-carrying peptides systemically at once, which compounds that same exposure.
  • Building a link or protocol around an injectable AHK-Cu route — it is topical-only here, and the calculator deliberately excludes it.

If you are using a pre-mixed blend

Because this compound is sold inside pre-mixed blend vials as well as on its own, one more arithmetic point matters: a blend label's milligram figure is the combined mass of all its components, and vendors do not standardise the per-component split. You cannot derive any single component's concentration from the blend total, and a volume figure that applied to one vendor's vial does not transfer to another's. Separate vials remove that ambiguity entirely, at the cost of more injections.

Related reading

GLOW — BPC-157 + TB-500 + GHK-CuKLOW — BPC-157 + TB-500 + GHK-Cu + KPVThe Peptide Stacking GuideAll stacking pages

Every combination described here is reported practice or mechanism-level reasoning. No controlled trial has studied any of these combinations, and nothing on this page is a personal protocol, a dose recommendation, or medical advice.